Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-092944

President & CEO sold 66,667 shares at $14.12 ($941,338)

  • President & CEO acquired 66,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-19 Exercise or conversion : show line 1 in the form +66,667 $6.46 $430,669 76,667 D
2016-01-19 Sale : show line 2 in the form −66,667 $14.12 $941,338 10,000 D
Open-market sales · 66,667 sh · avg $14.12 · $941,338

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-19 Exercise or conversion : show line 3 in the form Stock Option −66,667 $6.46 2016-02-24 66,667 66,666 D
Loading xslF345X03/doc4.xml…